Suppr超能文献

稳态和过敏状态下人动脉、静脉及肺微血管内皮细胞血管通透性的体外研究

In Vitro Investigation of Vascular Permeability in Endothelial Cells from Human Artery, Vein and Lung Microvessels at Steady-State and Anaphylactic Conditions.

作者信息

Callesen Katrine T, Yuste-Montalvo Alma, Poulsen Lars K, Jensen Bettina M, Esteban Vanesa

机构信息

Laboratory of Medical Allergology, Copenhagen University Hospital at Gentofte, DK-2900 Hellerup, Denmark.

Department of Allergy and Immunology, IIS-Fundación Jiménez Díaz, UAM, 28040 Madrid, Spain.

出版信息

Biomedicines. 2021 Apr 19;9(4):439. doi: 10.3390/biomedicines9040439.

Abstract

Human anaphylactic reactions largely involve an increase in vascular permeability, which is mainly controlled by endothelial cells (ECs). Due to the acute and serious nature of human anaphylaxis, in vivo studies of blood vessels must be replaced or supplemented with in vitro models. Therefore, we used a macromolecular tracer assay (MMTA) to investigate the EC permeability of three phenotypes of human ECs: artery (HAECs), vein (HSVECs) and microvessels from lung (HMLECs). ECs were stimulated with two fast-acting anaphylactic mediators (histamine and platelet-activating factor (PAF)) and one longer-lasting mediator (thrombin). At steady-state conditions, HSVEC monolayers were the most permeable and HMLEC the least (15.8% and 8.3% after 60 min, respectively). No response was found in ECs from artery or vein to any stimuli. ECs from microvessels reacted to stimulation with thrombin and also demonstrated a tendency of increased permeability for PAF. There was no reaction for histamine. This was not caused by missing receptor expression, as all three EC phenotypes expressed receptors for both PAF and histamine. The scarce response to fast-acting mediators illustrates that the MMTA is not suitable for investigating EC permeability to anaphylactic mediators.

摘要

人类过敏反应主要涉及血管通透性增加,这主要由内皮细胞(ECs)控制。由于人类过敏反应的急性和严重性,血管的体内研究必须用体外模型替代或补充。因此,我们使用大分子示踪剂测定法(MMTA)来研究三种人类ECs表型的EC通透性:动脉(HAECs)、静脉(HSVECs)和肺微血管(HMLECs)。用两种速效过敏介质(组胺和血小板活化因子(PAF))和一种长效介质(凝血酶)刺激ECs。在稳态条件下,HSVEC单层的通透性最高,HMLEC的通透性最低(60分钟后分别为15.8%和8.3%)。动脉或静脉的ECs对任何刺激均无反应。微血管的ECs对凝血酶刺激有反应,对PAF也表现出通透性增加的趋势。对组胺无反应。这不是由于缺乏受体表达,因为所有三种EC表型均表达PAF和组胺的受体。对速效介质的反应稀少表明MMTA不适合研究EC对过敏介质的通透性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2be/8072631/7579410ca38e/biomedicines-09-00439-g001.jpg

相似文献

3
Sphingosine-1-phosphate receptor 2 protects against anaphylactic shock through suppression of endothelial nitric oxide synthase in mice.
J Allergy Clin Immunol. 2013 Nov;132(5):1205-1214.e9. doi: 10.1016/j.jaci.2013.07.026. Epub 2013 Sep 8.
6
A biotinylated peptide, BP21, as a novel potent anti-anaphylactic agent targeting platelet-activating factor.
J Pept Sci. 2017 Sep;23(9):727-735. doi: 10.1002/psc.3019. Epub 2017 Jun 19.
8
Angiopoietin-1 inhibits endothelial permeability, neutrophil adherence and IL-8 production.
Br J Pharmacol. 2003 May;139(2):329-36. doi: 10.1038/sj.bjp.0705259.
10
Effect of ticagrelor on endothelial calcium signalling and barrier function.
Thromb Haemost. 2017 Jan 26;117(2):371-381. doi: 10.1160/TH16-04-0273. Epub 2016 Dec 1.

引用本文的文献

2
Establishment of the deuterium oxide dilution method as a new possibility for determining the transendothelial water permeability.
Pflugers Arch. 2024 Jun;476(6):993-1005. doi: 10.1007/s00424-024-02934-z. Epub 2024 Mar 5.
3
The bradykinin-forming cascade in anaphylaxis and ACE-inhibitor induced angioedema/airway obstruction.
Front Allergy. 2024 Jan 25;5:1302605. doi: 10.3389/falgy.2024.1302605. eCollection 2024.
4
In Vitro Models of Blood and Lymphatic Vessels-Connecting Tissues and Immunity.
Adv Biol (Weinh). 2023 May;7(5):e2200041. doi: 10.1002/adbi.202200041. Epub 2022 Jun 25.
5
Pathophysiological, Cellular, and Molecular Events of the Vascular System in Anaphylaxis.
Front Immunol. 2022 Mar 8;13:836222. doi: 10.3389/fimmu.2022.836222. eCollection 2022.

本文引用的文献

1
Regulation of vascular permeability in anaphylaxis.
Br J Pharmacol. 2018 Jul;175(13):2538-2542. doi: 10.1111/bph.14332. Epub 2018 May 22.
3
Beyond IgE-When Do IgE-Crosslinking and Effector Cell Activation Lead to Clinical Anaphylaxis?
Front Immunol. 2017 Aug 10;8:871. doi: 10.3389/fimmu.2017.00871. eCollection 2017.
4
The pathophysiology of anaphylaxis.
J Allergy Clin Immunol. 2017 Aug;140(2):335-348. doi: 10.1016/j.jaci.2017.06.003.
6
Vascular permeability--the essentials.
Ups J Med Sci. 2015;120(3):135-43. doi: 10.3109/03009734.2015.1064501. Epub 2015 Jul 29.
7
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.
Pharmacol Rev. 2015 Jul;67(3):601-55. doi: 10.1124/pr.114.010249.
9
Differential regulation of lung endothelial permeability in vitro and in situ.
Cell Physiol Biochem. 2014;34(1):1-19. doi: 10.1159/000362980. Epub 2014 Jun 16.
10
Experimental tools to monitor the dynamics of endothelial barrier function: a survey of in vitro approaches.
Cell Tissue Res. 2014 Mar;355(3):485-514. doi: 10.1007/s00441-014-1810-3. Epub 2014 Mar 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验